Moreover, our data indicates that the EGFR pathway controls the transdifferentiation of GSC from GBM to pericytes and that this process is mediated by the activation of Nuclear Factor kappa B (NF-κB) [20]. This evidence concerns the gene NFKB1 and glioblastoma.